Catalyst Wire Dossier Catalyst Wire Dossier

Human Corneal Endothelial Cell Therapy

human corneal endothelial cells · Aurion Biotech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Corneal Endothelial Cell Therapy, covering 2024-08-19 to 2024-08-19. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction [Phase 1]

See pricing